Hepatitis B virus (HBV) DNA assays (methods and practical use) and viral kinetics

被引：44

作者：

Pawlotsky, JM ^{[1
]}

机构：

[1] Univ Paris 12, Hop Henri Mondor, Dept Virol, EA 3489, F-94010 Creteil, France

来源：

JOURNAL OF HEPATOLOGY | 2003年 / 39卷

关键词：

D O I：

10.1016/S0168-8278(03)00136-3

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：S31 / S35

页数：5

共 47 条

[1] DETECTION AND QUANTITATION OF HEPATITIS-B VIRUS-DNA - COMPARISON OF 2 COMMERCIAL HYBRIDIZATION ASSAYS WITH POLYMERASE CHAIN-REACTION [J].

ASPINALL, S ;

STEELE, AD ;

PEENZE, I ;

MPHAHLELE, MJ .

JOURNAL OF VIRAL HEPATITIS, 1995, 2 (02) :107-111

[2] QUANTITATIVE DETECTION OF HEPATITIS-B VIRUS-DNA IN SERUM USING CHEMILUMINESCENCE - COMPARISON WITH RADIOACTIVE SOLUTION HYBRIDIZATION ASSAY [J].

BARLET, V ;

COHARD, M ;

THELU, MA ;

CHAIX, MJ ;

BACCARD, C ;

ZARSKI, JP ;

SEIGNEURIN, JM .

JOURNAL OF VIROLOGICAL METHODS, 1994, 49 (02) :141-151

[3] Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study [J].

Benhamou, Y ;

Bochet, M ;

Thibault, V ;

Calvez, V ;

Fievet, MH ;

Vig, P ;

Gibbs, CS ;

Brosgart, C ;

Fry, J ;

Namini, H ;

Katiama, C ;

Poynard, T .

LANCET, 2001, 358 (9283) :718-723

[4] Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients [J].

Benhamou, Y ;

Bochet, M ;

Thibault, V ;

Di Martino, V ;

Caumes, E ;

Bricaire, F ;

Opolon, P ;

Katlama, C ;

Poynard, T .

HEPATOLOGY, 1999, 30 (05) :1302-1306

[5] Comparison of three different sensitive assays for hepatitis B virus DNA in monitoring of responses to antiviral therapy [J].

Chan, HLY ;

Leung, NWY ;

Lau, TCM ;

Wong, ML ;

Sung, JJY .

JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (09) :3205-3208

[6] Clinical utility in quantifying serum HBV DNA levels using PCR assays [J].

Chu, CJ ;

Lok, ASF .

JOURNAL OF HEPATOLOGY, 2002, 36 (04) :549-551

[7] Evidence for the efficacy of peginterferon alfa-2a (40 KD) (pegasys) in the treatment of HBeAg-positive chronic hepatitis B (CHB) and impact of baseline factors [J].

Cooksley, WGE ;

Piratvisuth, T ;

Wang, YJ ;

Mahachai, V ;

Chao, YC ;

Tanwandee, T ;

Chutaputti, A ;

Chang, WY ;

Zahm, FE ;

Pluck, N .

JOURNAL OF HEPATOLOGY, 2002, 36 :8-8

[8] A PRELIMINARY TRIAL OF LAMIVUDINE FOR CHRONIC HEPATITIS-B INFECTION [J].

DIENSTAG, JL ;

PERRILLO, RP ;

SCHIFF, ER ;

BARTHOLOMEW, M ;

VICARY, C ;

RUBIN, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (25) :1657-1661

[9] Lamivudine as initial treatment for chronic hepatitis B in the United States [J].

Dienstag, JL ;

Schiff, ER ;

Wright, TL ;

Perrillo, RP ;

Hann, HWL ;

Goodman, Z ;

Crowther, L ;

Condreay, LD ;

Woessner, M ;

Rubin, M ;

Brown, NA .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (17) :1256-1263

[10] Extended lamivudine retreatment for chronic hepatitis B: Maintenance of viral suppression after discontinuation of therapy [J].

Dienstag, JL ;

Schiff, ER ;

Mitchell, M ;

Casey, DE ;

Gitlin, N ;

Lissoos, T ;

Gelb, LD ;

Condreay, L ;

Crowther, L ;

Rubin, M ;

Brown, N .

HEPATOLOGY, 1999, 30 (04) :1082-1087

← 1 2 3 4 5 →